A Multicenter Prospective Observational Study to Evaluate the Incidence of Post-ESD Bleeding in Patients Receiving Antithrombotic Therapy

Multicenter Prospective Observational Study of the Incidence of Post Endoscopic Submucosal Dissection Bleeding After Gastric ESD in Patients Receiving Antithrombotic Therapy - ATB-GESD Study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000060230

Enrollment

210

Registered

2025-12-29

Start date

2025-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric epithelial neoplasms

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who undergo ESD for gastric epithelial neoplasms

Exclusion criteria

Exclusion criteria: Patients in whom gastric ESD was discontinued Patients who underwent closure of the post-ESD ulcer Patients with unknown antithrombotic medication status Patients with unknown details regarding post-ESD bleeding

Design outcomes

Primary

Measure	Time frame
The incidence of post-gastric ESD bleeding	—

Countries

Japan

Contacts

Public ContactHITOSHI MORI

Nara Medical University Hospital Department of Gastroenterology

hitoshi-mori@naramed-u.ac.jp0744-22-3051

Outcome results